We are live on ! Find out more
IDXX icon

Idexx Laboratories

352 hedge funds and large institutions have $6.86B invested in Idexx Laboratories in 2014 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 93 increasing their positions, 131 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 28

120% more funds holding in top 10

Funds holding in top 10: 511 (+6)

48% more call options, than puts

Call options by funds: $3.84M | Put options by funds: $2.6M

10% more funds holding

Funds holding: 319352 (+33)

5% less capital invested

Capital invested by funds: $7.24B → $6.86B (-$383M)

29% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 131

Holders
352
Holders Change
+33
Holders Change %
+10.34%
% of All Funds
9.39%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.29%
New
65
Increased
93
Reduced
131
Closed
28
Calls
$3.84M
Puts
$2.6M
Net Calls
+$1.25M
Net Calls Change
+$3.4M
Name Holding Trade Value Shares
Change
Change in
Stake
RCG
1
Ruane, Cunniff & Goldfarb
New York
$660M -$105M -1,497,348 -14%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$659M -$207M -2,956,044 -25%
BAMCO Inc
3
BAMCO Inc
New York
$537M -$6.72M -95,810 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$438M +$5.93M +84,590 +1%
William Blair & Company
5
William Blair & Company
Illinois
$415M +$1.23M +17,584 +0.3%
Neuberger Berman Group
6
Neuberger Berman Group
New York
$290M +$20.6M +293,230 +8%
Select Equity Group
7
Select Equity Group
New York
$234M +$7.63M +108,832 +4%
BFA
8
BlackRock Fund Advisors
California
$216M -$13.1M -186,696 -6%
BIT
9
BlackRock Institutional Trust
California
$207M +$3.08M +43,902 +2%
State Street
10
State Street
Massachusetts
$183M -$12.1M -171,846 -7%
RA
11
Royce & Associates
New York
$148M -$21.3M -304,440 -13%
ACM
12
Atlanta Capital Management
Georgia
$135M -$1.16M -16,544 -0.9%
Wells Fargo
13
Wells Fargo
California
$129M +$101M +1,437,238 +474%
CC
14
Capital Counsel
New York
$121M -$1.91M -27,276 -2%
JP Morgan Chase
15
JP Morgan Chase
New York
$103M -$20.7M -295,310 -18%
JHIU
16
Janus Henderson Investors US
Colorado
$91.1M -$34.9M -497,376 -29%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$76.9M -$5.33M -75,976 -7%
Northern Trust
18
Northern Trust
Illinois
$74.2M -$3.72M -53,090 -5%
Federated Hermes
19
Federated Hermes
Pennsylvania
$69.6M +$13.8M +196,142 +26%
MAA
20
Managed Account Advisors
New Jersey
$64.1M +$44.1M +628,948 +267%
Ameriprise
21
Ameriprise
Minnesota
$62.1M +$1.27M +18,070 +2%
Norges Bank
22
Norges Bank
Norway
$60.5M +$2.83M +40,350 +5%
AI
23
Analytic Investors
California
$60.2M +$349K +4,978 +0.6%
Bank of America
24
Bank of America
North Carolina
$58M +$2.54M +36,232 +5%
Citadel Advisors
25
Citadel Advisors
Florida
$53M +$45.7M +652,004 +1,046%

IDXX Hedge Fund Activity: Q4 2014 in Review

352 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2014, worth a combined $6.86B — down 5.3% from $7.24B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new IDXX positions and 28 closed out — a net gain of 37 holders — while 93 added to existing stakes and 131 trimmed.

The largest buyer was Wells Fargo, adding an estimated $101M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $1.63B sold.

  • 352 institutional investors held Idexx Laboratories (IDXX) as of Q4 2014, up from 319 in Q3 2014.
  • Funds reported $6.86B of Idexx Laboratories stock for Q4 2014, down 5.3% quarter-over-quarter.
  • 65 funds opened new Idexx Laboratories positions in Q4 2014 and 28 closed out, a net change of +37 holders.
  • The largest Idexx Laboratories buyer in Q4 2014 was Wells Fargo, an estimated $101M added.
  • The largest Idexx Laboratories seller in Q4 2014 was Americafirst Capital Management, an estimated $1.63B sold.

Based on aggregated 13F filings for Q4 2014.